Please use this identifier to cite or link to this item:
|Title:||The effects of a plant proteinase inhibitor from Enterolobium contortisiliquum on human tumor cell lines|
|Authors:||Nakahata, Adriana Miti [UNIFESP]|
Andrade de Paula, Claudia Alessandra [UNIFESP]
Sampaio, Misako U. [UNIFESP]
Oliva, Maria Luiza V. [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
mesenchymal stem cells
|Publisher:||Walter de Gruyter & Co|
|Citation:||Biological Chemistry. Berlin: Walter de Gruyter & Co, v. 392, n. 4, p. 327-336, 2011.|
|Abstract:||Supplementary to the efficient inhibition of trypsin, chymotrypsin, plasma kallikrein, and plasmin already described by the EcTI inhibitor from Enterolobium contortisiliquum, it also blocks human neutrophil elastase (K(iapp)=4.3 nM) and prevents phorbol ester (PMA)-stimulated activation of matrix metalloproteinase (MMP)-2 probably via interference with membrane-type 1 (MT1)-MMP. Moreover, plasminogen-induced activation of proMMP-9 and processing of active MMP-2 was also inhibited. Furthermore, the effect of EcTI on the human cancer cell lines HCT116 and HT29 (colorectal), SkBr-3 and MCF-7 (breast), K562 and THP-1 (leukemia), as well as on human primary fibroblasts and human mesenchymal stem cells (hMSCs) was studied. EcTI inhibited in a concentration range of 1.0-2.5 mu M rather specifically tumor cell viability without targeting primary fibroblasts and hMSCs. Taken together, our data indicate that the polyspecific proteinase inhibitor EcTI prevents proMMP activation and is cytotoxic against tumor cells without affecting normal tissue remodeling fibroblasts or regenerative hMSCs being an important tool in the studies of tumor cell development and dissemination.|
|Appears in Collections:||Em verificação - Geral|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.